Author: Fiona Craig
-
Dawson Geophysical rises 3% after strong Q4 performance and upbeat outlook
Dawson Geophysical Company (NASDAQ:DWSN) reported better-than-expected fourth-quarter results on Monday, sending its shares higher in early trading. The seismic data acquisition services provider saw its stock gain 2.95% in pre-market trading following the announcement. Fourth-quarter revenue climbed to $27.0 million, marking a 72% increase from $15.6 million in the same period a year earlier. Fee…
-
Falcon’s Beyond posts Q4 loss as revenue rises; shares tick up
Falcon’s Beyond Global, Inc. (NASDAQ:FBYD) reported a net loss of $0.3 million, or -$0.01 per share, for the fourth quarter on Tuesday. The entertainment and technology group generated $6.6 million in consolidated revenue, up sharply from $1.4 million a year earlier, largely reflecting contributions from its newly established Falcon’s Attractions segment. The company’s shares gained…
-
Oil holds above $110 as Middle East conflict fuels sharp March rally
Oil prices remained above $110 per barrel on Tuesday as markets balanced news of a tanker fire near Dubai with reports that U.S. President Donald Trump may be considering ending military operations against Iran. By 04:49 ET (08:49 GMT), Brent crude futures for May delivery, the global benchmark, were up 0.1% at $112.87 per barrel,…
-
Gold edges higher as markets watch Iran de-escalation; metal still heading for steep March losses
Gold prices climbed during Asian trading on Tuesday, recovering slightly after suffering heavy declines throughout March as rising inflation expectations tied to the U.S.–Israel conflict with Iran weighed on non-yielding assets such as precious metals. Sentiment in metals markets improved after reports indicated that U.S. President Donald Trump is weighing the possibility of scaling back…
-
Futures rise while oil stays elevated amid Iran conflict — key market drivers: Dow Jones, S&P, Nasdaq, Wall Street
U.S. equity futures moved higher on Tuesday as investors looked ahead to the final trading day of the first quarter, supported by reports that U.S. President Donald Trump may be considering ending the military campaign in Iran even if the Strait of Hormuz remains closed. Energy markets, however, stayed under pressure after a Kuwaiti oil…
-
Mobix Labs (MOBX): Doubling Down on the “Drone Wars” Economy
For retail investors following the defense tech space, March 2026 is shaping up to be a pivotal month for Mobix Labs (NASDAQ:MOBX). The company just dropped two major updates that signal a strategic shift from being a “component supplier” to becoming a “systems intelligence” player. This article is disseminated in partnership with Mobix Labs Inc. It…
-
Kezar Life Sciences shares surge after Aurinia announces acquisition
Kezar Life Sciences Inc. (NASDAQ:KZR) shares jumped about 19% on Monday after Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) announced an agreement to acquire the company for $6.955 per share in cash plus a contingent value right (CVR). Under the terms of the deal, the CVR could provide additional payments tied to the clinical development or potential sale…
-
MakeMyTrip shares slide after short-seller report raises allegations
MakeMyTrip Limited (NASDAQ:MMYT) shares declined about 3.5% on Monday after Morpheus Research released a short-seller report alleging anti-competitive behavior and accounting concerns at the Indian online travel company. The report claims MakeMyTrip continues to apply price parity practices with hotel partners despite a 2022 ruling by India’s Competition Commission of India (CCI) ordering the company…
-
Nexstar shares drop after judge orders pause in Tegna merger
Shares of Nexstar Media Group (NASDAQ:NXST) fell about 9% on Monday after a federal judge ordered the broadcaster to halt further integration efforts tied to its recently completed merger with Tegna Inc. U.S. District Judge Troy L. Nunley in Sacramento granted a request from DirecTV to temporarily stop the deal while litigation over the merger…
-
Insmed shares rise after UTHR trial data and Morgan Stanley upgrade
Insmed (NASDAQ:INSM) shares climbed about 4.7% on Monday after analysts reacted to positive clinical data from United Therapeutics and Morgan Stanley upgraded the stock to Overweight from Equalweight. Morgan Stanley also raised its price target on Insmed to $212 from $166 after conducting proprietary survey research on the launch of Brinsupri for bronchiectasis. The firm’s…